Posted On: 13 Jul 2026
A Notice of Allowance was received for a US patent application covering the ‘crystalline form of sofpironium bromide and preparation method thereof,’ which is expected to provide additional protections against unauthorisedcommercial manufacturing of Sofdra’s drug substance into May 2040.